Daiwa Securities Group »

Entrada Therapeutics shares owned by Daiwa Securities Group

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Daiwa Securities Group from 13F filings

Historical chart of Daiwa Securities Group investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Daiwa Securities Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Daiwa Securities Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0k 150 6.67
2025-06-30 $1.0k 150 6.67
2025-03-31 $1.0k 150 6.67

More positions owned by Daiwa Securities Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Welltower Inc Com reit (WELL)
Netflix Common stock (NFLX)
Digital Realty Trust (DLR)
Crowdstrike Hldgs Cl A (CRWD)
Servicenow (NOW)
Prologis (PLD)
Invitation Homes (INVH)
Global X Fds Conscious Cos (KRMA)

View all positions for Daiwa Securities Group

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
BlackRock
Vanguard Group
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
Renaissance Technologies
TCG Crossover Management
State Street Corporation
Dimensional Fund Advisors
Royce & Associates
Citadel Advisors

View all funds holding Entrada Therapeutics